Mitochondrial Dysfunction: A Common Hallmark Underlying Comorbidity between sIBM and Other Degenerative and Age-Related Diseases
Open Access
- 13 May 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (5), 1446
- https://doi.org/10.3390/jcm9051446
Abstract
Sporadic inclusion body myositis (sIBM) is an inflammatory myopathy associated, among others, with mitochondrial dysfunction. Similar molecular features are found in Alzheimer’s disease (AD) and Type 2 Diabetes Mellitus (T2DM), underlying potential comorbidity. This study aims to evaluate common clinical and molecular hallmarks among sIBM, AD, and T2DM. Comorbidity with AD was assessed in n = 14 sIBM patients by performing neuropsychological and cognitive tests, cranial magnetic resonance imaging, AD cerebrospinal fluid biomarkers (levels of amyloid beta, total tau, and phosphorylated tau at threonine-181), and genetic apolipoprotein E genotyping. In the same sIBM cohort, comorbidity with T2DM was assessed by collecting anthropometric measures and performing an oral glucose tolerance test and insulin determinations. Results were compared to the standard population and other myositis (n = 7 dermatomyositis and n = 7 polymyositis). Mitochondrial contribution into disease was tested by measurement of oxidative/anaerobic and oxidant/antioxidant balances, respiration fluxes, and enzymatic activities in sIBM fibroblasts subjected to different glucose levels. Comorbidity of sIBM with AD was not detected. Clinically, sIBM patients showed signs of misbalanced glucose homeostasis, similar to other myositis. Such misbalance was further confirmed at the molecular level by the metabolic inability of sIBM fibroblasts to adapt to different glucose conditions. Under the standard condition, sIBM fibroblasts showed decreased respiration (0.71 ± 0.08 vs. 1.06 ± 0.04 nmols O2/min; p = 0.024) and increased anaerobic metabolism (5.76 ± 0.52 vs. 3.79 ± 0.35 mM lactate; p = 0.052). Moreover, when glucose conditions were changed, sIBM fibroblasts presented decreased fold change in mitochondrial enzymatic activities (−12.13 ± 21.86 vs. 199.22 ± 62.52 cytochrome c oxidase/citrate synthase ratio; p = 0.017) and increased oxidative stress per mitochondrial activity (203.76 ± 82.77 vs. −69.55 ± 21.00; p = 0.047), underlying scarce metabolic plasticity. These findings do not demonstrate higher prevalence of AD in sIBM patients, but evidences of prediabetogenic conditions were found. Glucose deregulation in myositis suggests the contribution of lifestyle conditions, such as restricted mobility. Additionally, molecular evidences from sIBM fibroblasts confirm that mitochondrial dysfunction may play a role. Monitoring T2DM development and mitochondrial contribution to disease in myositis patients could set a path for novel therapeutic options.Funding Information
- Instituto de Salud Carlos III (PI1800498, PI1800451)
- Departament de Salut, Generalitat de Catalunya (PERIS SLT008/18/00061)
This publication has 59 references indexed in Scilit:
- Primary Skin Fibroblasts as a Model of Parkinson's DiseaseMolecular Neurobiology, 2012
- Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30‐year epidemiologic study of histology‐proven casesInternational Journal of Rheumatic Diseases, 2011
- Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es StudyDiabetologia, 2011
- Boston Diagnostic Aphasia ExaminationPublished by Springer Science and Business Media LLC ,2011
- Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitusInternational Journal of Rheumatic Diseases, 2010
- Development and implementation of standardized respiratory chain spectrophotometric assays for clinical diagnosisMitochondrion, 2009
- Spanish Multicenter Normative Studies (NEURONORMA Project): Norms for Verbal Fluency TestsArchives of Clinical Neuropsychology, 2009
- Category test and trail making test as measures of frontal lobe functionsThe Clinical Neuropsychologist, 1995
- Genuine memory deficits in dementiaDevelopmental Neuropsychology, 1987
- THE PANCREATIC ISLET CELLS IN INSULAR AMYLOIDOSIS IN HUMAN DIABETIC AND NON‐DIABETIC ADULTSActa Pathologica Microbiologica Scandinavica Section A Pathology, 1973